Related Experiment Video
Updated: Jul 9, 2026
A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
Published on: June 14, 2024
Persistent impairments in muscle function and symptom burden in post-COVID syndrome: a prospective longitudinal study
Michael Wunderle1, Andrea Ribeiro2, Isabelle Lethen2
1Department of Nephrology, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany. Michael.Wunderle@mri.tum.de.
Background:
Post-COVID syndrome (PCS) is characterized by persistent heterogeneous symptoms after SARS-CoV-2 infection, yet objective biomarkers for symptom severity and longitudinal disease trajectories remain limited. We aimed to characterize muscle function over time in PCS and examine its relationship with symptom burden and neuroaxonal injury markers.
Methods:
In this prospective observational study, patients fulfilling WHO criteria for PCS underwent standardized assessments at baseline (BL) and six-month follow-up (FU). Muscle function was assessed using a multidimensional handgrip strength (HGS) protocol capturing mean force (Fmean), fatigability (fatigue ratio), and recovery capacity alongside clinical symptom measures. Analyses included longitudinal assessment within the PCS cohort, comparisons with COVID-19 recovered controls, analysis of symptom persistence, and matched cohort analyses including HGS measures and circulating neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP).
Results:
Among 204 participants (102 PCS, 102 recovered controls) PCS patients showed lower Fmean and higher fatigability at BL and FU (both p < 0.01). Muscle function parameters remained largely stable over six months, with only modest improvement in recovery (p = 0.015). HGS parameters correlated with symptom burden (ρ ≈ -0.28 to -0.33), and BL impairments were associated with worse fatigue and depressive symptoms at FU (e.g., Fmean-PHQ-9: β = -0.11, p = 0.022; fatigue ratio-FSS: β = 1.66, p = 0.008). Exploratory analyses suggested slightly higher NfL and GFAP levels in PCS in some models, without consistent associations with muscle function or symptoms.
Conclusions:
HGS is persistently reduced in PCS over at least six months and aligns with symptom burden. Multidimensional HGS assessment may provide a practical objective marker of functional impairment and symptom persistence in PCS. Neuroaxonal injury markers showed modest elevations in PCS in some analyses but appeared unrelated to muscle performance, suggesting partially distinct mechanisms.
Trial Registration:
ClinicalTrials.gov, NCT05635552. Registered 1 December 2022 - Retrospectively registered, https://clinicaltrials.gov/study/NCT05635552?term=NCT05635552&rank=1&tab=study.
Related Concept Videos
01:11Alterations in Muscle Tone lll
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:22Myasthenia Gravis ll: Pathophysiology
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...